Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis. Comparative Effectiveness Rev
Objective. We conducted a systematic review to examine the long-term consequences of discontinuing disease-modifying treatment (DMT) for multiple sclerosis (MS) by examining the long-term benefits and harms, and the reasons for discontinuing treatment. We also examined the
evidence for people’s values, beliefs, and preferences regarding discontinuing DMT.
Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2012-00016-I
AHRQ Publication No.15-EHC012-EF
Copyright to this work is held by the author(s), in accordance with United States copyright law (USC 17). Readers of this work have certain rights as defined by the law, including but not limited to fair use (17 USC 107 et seq.). Questions regarding copyright and use issues should be directed to the publishers or rights holders of each individual work. Questions regarding this collection may be directed to the Northwestern Health Sciences University Greenawalt Library at 952-885-5419 or at firstname.lastname@example.org.
Agency For Healthcare Research and Quality